Changes in Beneficial Ownership · 4

MiniMed Group, Inc.

Changes in Beneficial Ownership

Filed Oct 16, 2026Accepted Oct 16, 2026, 5:18 PM EDTFiling CIK 2062583Accession 0001532133-26-000006

View company →Permanent SEC source ↗

Structured filing — 4

wk-form4_1792185531.xml

Open full document ↗

Filing details

Report period: 2026-10-15
Issuer: MiniMed Group, Inc.
Issuer CIK: 0002062583
Trading symbol: MMED

Reporting owner 1

Name: Endicott David J.
Reporting owner CIK: 0001532133
Relationship: Director
Address: C/O MINIMED GROUP, INC., 18000 DEVONSHIRE STREET, NORTHRIDGE, CA, 91325

Non-derivative transactions

Non-derivative transactions · 1 reported row
Security	Transaction date	Code	Amount	A / D	Price (USD)	Owned after	Ownership
Common Stock	2026-10-15	A · Form 4	3,374^[F1]	A	0	15,169^[F2]	D

Table key

A · Form 4: Acquisition by grant, award or otherwise under Rule 16b-3(d)
A: Acquired
D: Direct

Footnotes

F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on October 9, 2027.↩ 1
F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.↩ 1

Signature 1

Signed: /s/ Bryan F. Kelly, attorney-in-fact
Date: 2026-10-16

Company context

We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes.

Current securities

MMEDNASDAQ · EQUITY · Current

Historical securities (3)

MMEDVNASDAQ · EQUITY · Historical · closed Oct 16, 2026 MMED.WANEO · EQUITY · Historical · closed Dec 8, 2023 MMED.WRNEO · EQUITY · Historical · closed Jan 5, 2024

Get the free weekly BCS email.